HOME >> MEDICINE >> NEWS
Balancing care decisions for gravely ill patients

ROCHESTER, Minn. -- Mayo Clinic researchers studying gravely ill intensive care unit (ICU) patients found that unrealistic family expectations resulted in the increased use of health care resources without a significant improvement in survival rate among these patients.

The February Mayo Clinic Proceedings study is important for patients who have a high likelihood of death in a hospital. Early, accurate identification of these patients when they arrive at the hospital might limit potentially futile, aggressive ICU care to such patients. However, limiting such aggressive care based on inaccurate tools might shorten potentially productive lives, says Keith Berge, M.D., a Mayo Clinic anesthesiologist who was the lead researcher.

In this study, researchers used the Acute Physiology and Chronic Health Evaluation III (APACHE III), a computerized system that is designed to prospectively predict mortality rates in "real time" for ICU patients, to identify a group of patients with a very low predicted likelihood of survival. This group of extremely ill patients was then looked at in more detail.

The researchers compared a group of these patients in which the families had unrealistic expectations of survival with a group of patients whose families' expectations were deemed appropriate. They found that patients whose families had unrealistic expectations used substantially more ICU resources. The median number of days in ICU for all patients was four, while the median number of days in ICU for patients whose families had unrealistic expectations was 11 days. While these patients survived to hospital discharge at a higher rate than others (33 percent versus 17 percent), their survival one year later did not differ much from those without documentation of unrealistic expectations (11 percent versus 6 percent). Nearly all survivors were severely disabled at discharge and at one year.

"Perhaps the best way to avoid vast expenditures of resources on
'"/>


1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Accountability in Clinical Research: Balancing Risk and Benefit
2. How the stories of ordinary people could give them more say over planning decisions
3. Web-based tool to help clinicians make schizophrenia treatment decisions
4. Fair decisions more important when hospitals face crisis like SARS
5. Concerns about fertility affect treatment decisions in one-third of young breast cancer patients
6. European study highlights frequency of medical end-of-life decisions in terminally ill pts
7. Brain imaging study reveals interplay of thought and emotion in economic decisions
8. Peer pressure matters in young adults smoking decisions
9. Computerized tool predicts sarcoma outcome and improves ability to make better treatment decisions
10. Hormonal treatment improves survival in high-risk prostate cancer patients
11. Study finds that coordinating care of chronically ill patients does not increase liability

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Balancing care decisions for gravely ill patients

(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... 2015 Vancouver personal injury lawyers at Jiwa ... affected by time limits. They stated that in many cases, ... or even nullify it. Many a time, delays in making ... rights under BC law. As a result, experts at Jiwa ... should consult a personal injury lawyer in order to know ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Indosoft ... software suite for Asterisk, are pleased to announce the ... successful 5.7 and 5.8 versions of Q-Suite, this new ... as a number of new features to the leading ... 2015. , Q-Suite 5.9 will add features to enhance ...
(Date:2/28/2015)... A study out of the University of Oxford ... the treatment of a hereditary ocular condition that leads ... Dr. Robert MacLaren, professor of ophthalmology at the University ... on January 16, 2014 , the study treated six ... mostly affects men and leads to the degeneration of ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
(Date:2/27/2015)... 2015 Roughly three-quarters of pharmacists said ... an interchangeable biosimilar for its branded biologic counterpart ... name, according to a survey published in the ... of Managed Care & Specialty Pharmacy (JMCP). ... pharmacists would feel as confident if the products ...
(Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
(Date:2/27/2015)... 27, 2015 The role of the Medical ... one thing hasn,t changed: face-to-face meetings are seen as ... Key Opinion Leaders. Yet at the same ... type of interaction, field medical teams within the pharmaceutical ... This is just one of the challenges addressed in ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2
Cached News: